Peer Review History
| Original SubmissionAugust 4, 2024 |
|---|
|
PONE-D-24-32977Gellan gum-based granular gels as suspension media for biofabricationPLOS ONE Dear Dr. Melchels, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Oct 23 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Pradeep Kumar, Ph.D. Academic Editor PLOS ONE Journal Requirements: 1. When submitting your revision, we need you to address these additional requirements. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf. 2. Thank you for stating the following financial disclosure: [AM EP/R513040/1 Engineering and Physical Sciences Research Council through their Doctoral Training Programme https://www.ukri.org/councils/epsrc/]. Please state what role the funders took in the study. If the funders had no role, please state: ""The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."" If this statement is not correct you must amend it as needed. Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf. 3. Thank you for stating the following in the Acknowledgments Section of your manuscript: [We acknowledge the financial support from the Engineering and Physical Sciences Research Council through their Doctoral Training Programme (EP/R513040/1)] We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows: [AM EP/R513040/1 Engineering and Physical Sciences Research Council through their Doctoral Training Programme https://www.ukri.org/councils/epsrc/]. Please include your amended statements within your cover letter; we will change the online submission form on your behalf. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: No Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: This paper presents a new method to create gellan gum based suspension media for extrusion bioprinting. The rheological properties of the obtained suspension baths were found favorable over a wide range of temperatures (4-37 degrees Celsius). This is a remarkable property because it enables to set the suspension bath's temperature to the optimal print nozzle temperature according to the requirements imposed by the bioink. Moreover, the study illustrates the use of the novel suspension media in the context of both extrusion-based printing and micro-valve bioprinting. In my opinion, this is a valuable contribution to the bioprinting literature and its impact could be further increased by addressing the following weak points: 1. The terms "droplet printing by jetting" (line 221), "electromagnetic droplet printing" (line 334), and "droplet jetting" (line 370) are confusing because they deviate from the professional jargon of bioprinting. Please use instead "micro-valve bioprinting", the common term described in detail in the following references (I am not a coauthor of them): Gudapati H et al. A comprehensive review on droplet-based bioprinting: past, present and future. Biomaterials 2016, 102, doi:10.1016/j.biomaterials.2016.06.012. Sun W et al. The bioprinting roadmap. Biofabrication 2020, 12, 022002, doi:10.1088/1758-5090/ab5158. 2. The description of extruded strand morphology versus nozzle translational velocity (printing speed) (lines 239-241) is accurate but too narrow. It is important to note that tortuous strands can result also in direct extrusion-based printing onto solid substrates provided that the stand-off distance is large enough and the printing speed is set well below the extrusion speed. The following work by Yuk and Zhao is an excellent study of strand morphology in direct ink writing: Yuk H and Zhao X. A New 3D Printing Strategy by Harnessing Deformation, Instability, and Fracture of Viscoelastic Inks. Advanced Materials 2018, 30, 1704028, doi:10.1002/adma.201704028. 3. The list of printing parameters provided in the captions of Figures 3 and S1 should also include the stand-off distance (the distance between the nozzle's tip and the substrate). 4. In the Discussion, the authors suggest that the thinning of an extruded hydrogel strand with increasing printing speed occurs due to surface tension (lines 360-361). It is true, the Laplace pressure, of the order of hundreds of Pa in the case of the air-ink interface, contributes to smoothing the extruded strand. Nevertheless, the strand's diameter is determined by volume conservation, which explains why it is inversely proportional to the square root of the printing speed. The print resolution is also influenced by the extrudate swell effect (also known as the Barus effect or die-swelling): as the extruded hydrogel strand leaves the nozzle, its diameter becomes larger than the nozzle's orifice because of the relaxation of the hydrogel's polymer filament network. This effect is mentioned by the authors on line 379, in the context of droplet bioprinting. If the printing speed matches the dispensing velocity (extrusion speed) the filament is deposited as is (i.e. its diameter will be equal to the nozzle's inner diameter multiplied by the extrudate swell ratio). If the printing speed exceeds the extrusion speed, the filament is stretched on-the-fly (since it is anchored to the substrate by adhesion forces) and its diameter can be computed from volume conservation. Upon deposition onto a solid substrate (e.g. TCPS), it flattens to a certain extent, depending on the ink-substrate contact angle as well as on the ink's yield stress and shear thinning behavior. I apologize for this long comment! I did not intend to lecture the authors; I just tried to illustrate how complex a problem is to predict the resolution of extrusion-based bioprinting. Theoretical studies are available in the literature for both direct and suspended extrusion bioprinting. The authors have the option to extend their discussion, providing a more accurate description of the observed fenomena, or to refrain from discussing the mechanisms responsible for their experimental findings. 5. Section 5 (Conclusion) is, in fact, a reiteration of the Abstract. In this part, it is fine to start with a brief summary of what has been achieved, but one should also attempt to explain the potential impact of the reported results and the perspectives of the proposed approach. Such comments are included the Discussion, but no take-home message is provided in the last section. Minor remarks and revisions: Line 19: I would stick to a single tense in the Abstract. It starts in simple present and switches midway to past tense. One option is to reformulate "Furthermore, printing of cell-laden droplets maintained over 7-day was demonstrated" as "Furthermore, we demonstrate the printing of cell-laden droplets maintained over 7 days". Line 179: In the paragraph dedicated to statistical analysis, please state that "The level of statistical significance was set to p = 0.05." Lines 223-224: Here, I would write "gellan gum suspension media (GGSM)" and "tissue culture polystyrene (TCPS)" (i.e. without 3D and 2D, respectively.) These are the acronyms used later on. Line 252 and 257: Instead of "S1", please write "Supporting Information, Figure S1" and then, on line 257, please replace "S2" with "Figure S2". Line 300: Instead of "Following printing of this structure," I would write "Post printing,". Line 313: In the caption of Figure 6, I would keep "n = 5" as part of the sentence: instead of " suspension media). n =5" I would write " suspension media; n = 5)." Line 316: Instead of "The Young’s moduli, a key determinant" consider writing "Young’s modulus, a key determinant". Lines 321-323: Mathematical symbols (E, c) are usually typeset in Italic, using an equation editor. Line 390: Instead of "extrusion-based printing", please write "extrusion-based bioprinting". Line 397: Please replace "by approximately 2x" with "about twofold". Line 408: Please consider revising "permitting the ability" as "allowing". Reviewer #2: The manuscript discusses work pertaining to the suitability of granular gellan gum gels as suspension media for 3D bioprinting of cell-laden inks. The effects of gel concentration, temperature and rheology are described in terms of how such granular gels support 3D printed structures while achieving suitable printing speeds and resolutions. The manuscript is concise and well-written in a simple manner which makes it understandable and readable to various academic levels of audience. The rationale of the study is well-outlined in the introduction. The results support the hypothesis and reflect the objectives of the study. Below are some minor points to consider: 1. Line 19: amend to " 7 days" 2. Line 58: "suspension media" 3. Reference should be included for lines 67-68 4. Suggested to include a brief definition or explanation of "jammed granular network" in the introduction. 5. In materials and methods, it is suggested to include the concentrations of gellan gum and gelMA used, including the ratios of gellan gum:gelMA for the photo-curable medium. 5. Please include the time duration of shearing of the gellan gum gels at 600 rpm. 6. Line 127: replace full stop with a comma between "stress-controlled" and "single frequency. 7. Line 149: "G-code" include hyphen. 8. Line 169: amend to ",...which contained bubbles were excluded, n = 5..." 9. Line 367: amend to "brain tissue or of the epithelium of..." ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Gellan gum-based granular gels as suspension media for biofabrication PONE-D-24-32977R1 Dear Dr. Melchels, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Pradeep Kumar, Ph.D. Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The authors have addressed all the concerns expressed in my previous referee report. I think this is a nice paper that might elicit the interest of the bioprinting community. Reviewer #2: All comments have been addressed. I believe this manuscript can be accepted for publication. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No ********** |
| Formally Accepted |
|
PONE-D-24-32977R1 PLOS ONE Dear Dr. Melchels, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Prof. Pradeep Kumar Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .